Globeimmune (OTCMKTS:GBIM) Shares Break Above 50-Day Moving Average – Time to Sell?

Globeimmune, Inc. (OTCMKTS:GBIM) shares passed above its 50 day moving average during trading on Friday. The stock has a 50 day moving average of $0.00 and traded as high as $0.0001. Globeimmune shares last traded at $0.00, with a volume of 0 shares.

Globeimmune Trading Down 100.0%

About Globeimmune

GlobeImmune, Inc was a biotechnology company focused on developing immunotherapies for cancer and infectious diseases. The company’s research was based on its Tarmogen platform, which used genetically engineered yeast to present disease-associated antigens and stimulate targeted immune responses.

GlobeImmune’s historical development programs included GI-4000, an investigational therapeutic vaccine designed to target cancer-associated KRAS mutations, as well as other vaccine candidates aimed at solid tumors and chronic viral infections.